Vats Vaibhav, Elahi Aarij, Hidri Sinda, Abdelkader Rem Ehab, Munaf Farhan, Prince Jennifer Mercika, Asif Muhammad Ahsan, Cheema Huzaifa Ahmad, Ahmad Adeel, Rehman Wajeeh Ur, Nashwan Abdulqadir J, Ahmed Raheel, Lakhter Vladimir, Virk Hafeez Ul Hassan, Vincent Royce P
Department of Medicine, Smt. Kashibai Navale Medical College and General Hospital, Pune, India.
Department of Medicine, Royal Glamorgan Hospital, Pontyclun, United Kingdom.
Front Cardiovasc Med. 2024 May 31;11:1395606. doi: 10.3389/fcvm.2024.1395606. eCollection 2024.
Optical coherence tomography (OCT) and intravascular ultrasound (IVUS) are superior to coronary angiography for guiding percutaneous coronary intervention (PCI). However, whether one technique is superior to the other is inconclusive.
We searched PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov from inception to November 2023 for randomized controlled trials (RCTs) comparing OCT and IVUS in patients undergoing PCI. RevMan 5.4 was used to pool outcomes with risk ratio (RR) as the effect measure.
Six RCTs (4,402 patients) were included in this meta-analysis. There was no significant difference between the OCT- and IVUS-guided PCI groups in the risk of major adverse cardiovascular events (RR 0.87, 95% CI: 0.65, 1.16; I= 0%) and cardiac mortality (RR 0.73, 95% CI: 0.24, 2.21; I= 0%). The results were consistent across the subgroups of the presence or absence of left main disease (P >0.1). There were no significant differences between OCT and IVUS in the risk of target lesion revascularization (RR 0.78, 95% CI: 0.47, 1.30; I= 0%), target vessel revascularization (RR 1.06, 95% CI: 0.69, 1.62; I= 0%), target-vessel myocardial infarction (RR 0.79, 95% CI: 0.40, 1.53; I= 0%), stent thrombosis (RR 0.59, 95% CI: 0.12, 2.97; I= 0%), and all-cause mortality (RR 1.01, 95% CI: 0.53, 1.90; I= 0%).
Our meta-analysis demonstrated similar clinical outcomes in OCT- and IVUS-guided PCI. New large-scale multicenter RCTs with long-term follow-up are required to confirm or refute our findings and provide more reliable results.
PROSPERO, identifier, CRD42023486933.
光学相干断层扫描(OCT)和血管内超声(IVUS)在指导经皮冠状动脉介入治疗(PCI)方面优于冠状动脉造影。然而,一种技术是否优于另一种技术尚无定论。
我们检索了从创刊至2023年11月的PubMed、Embase、Cochrane图书馆和ClinicalTrials.gov,以查找比较接受PCI患者的OCT和IVUS的随机对照试验(RCT)。使用RevMan 5.4汇总结果,以风险比(RR)作为效应量度。
本荟萃分析纳入了6项RCT(4402例患者)。OCT引导组和IVUS引导组在主要不良心血管事件风险(RR 0.87,95%CI:0.65,1.16;I=0%)和心源性死亡率(RR 0.73,95%CI:0.24,2.21;I=0%)方面无显著差异。在有或无左主干病变的亚组中结果一致(P>0.1)。OCT和IVUS在靶病变血运重建风险(RR 0.78,95%CI:0.47,1.30;I=0%)、靶血管血运重建风险(RR
1.06,95%CI:0.69,1.62;I=0%)、靶血管心肌梗死风险(RR 0.79,95%CI:0.40,1.53;I=0%)、支架血栓形成风险(RR 0.59,95%CI:0.12,2.97;I=0%)和全因死亡率(RR 1.01,95%CI:0.53,1.90;I=0%)方面无显著差异。
我们的荟萃分析表明,OCT引导和IVUS引导的PCI临床结果相似。需要新的大规模多中心RCT进行长期随访,以证实或反驳我们的发现并提供更可靠的结果。
PROSPERO,标识符,CRD42023486933。